Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

SMMTSMMT
21 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in SUMMIT THERAPEUTICS INC

CITADEL ADVISORS LLC holds 1.7M shares of SMMT (SUMMIT THERAPEUTICS INC), worth $25.1M as of 2026-Q2. The position was increased (+290.7% shares). SMMT represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$25.1M

Current Shares

1.7M

Total Value Change

+$25.1M

Total Shares Change

+1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+290.7%
$25.1M0.0%$14.57
46
2026-Q1
Decreased
441,743
-82.2%
$8.4M0.0%$15.11
0
2025-Q4
Increased
2.5M
+1121.3%
$43.3M0.0%$17.49
47
2025-Q3
Increased
202,712
+97.9%
$4.2M0.0%$21.16
43
2025-Q2
Decreased
102,417
-89.8%
$2.2M0.0%$20.60
0
2025-Q1
Increased
998,740
+432.9%
$19.3M0.0%$20.32
46
2024-Q4
Decreased
187,407
-71.2%
$3.3M0.0%$17.89
0
2024-Q3
New
650,833
-
$14.3M0.0%$20.89
39
2024-Q2
Exited
0
-100.0%
$00.0%$7.80
0
2024-Q1
New
5
-
$210.0%$4.14
17
2023-Q2
Exited
0
-100.0%
$00.0%$2.51
0
2023-Q1
Decreased
22,381
-53.7%
$39,1670.0%$1.63
0
2022-Q4
New
48,378
-
$205,6070.0%$4.25
35
2022-Q3
Exited
0
-100.0%
$00.0%$1.15
0
2022-Q2
New
56,743
-
$57,0000.0%$0.97
32
2022-Q1
Exited
0
-100.0%
$00.0%$2.58
0
2021-Q4
New
42,593
-
$115,0000.0%$2.55
34
2021-Q3
Exited
0
-100.0%
$00.0%$4.83
0
2021-Q2
Decreased
25,618
-39.9%
$191,0000.0%$7.43
0
2021-Q1
Increased
42,591
+163.4%
$250,0000.0%$5.60
37
2020-Q4
New
16,170
-
$76,0000.0%$5.02
33

Other major holders of SMMT: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used